FemInEM
AdvocacySupport
Abortion access
Mifepristone safety and efficacy
Removal of rems restrictions
Citizen Petition from GenBioPro, Inc.
FDA-2025-P-2162-0001Other
Comments
120
Last activity Jul 1, 2026
Deadline
--
Net supportiSupport minus oppose · campaigns included
-58%
-58% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from GenBioPro, Inc.
- Posted
- Jul 7, 2025
- Comment period
- Jul 7, 2025 – ?
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
-58%
Net support
Support22Oppose92Other6
Aggregates include form-letter campaigns. Excluding them, net support is -58% across organic comments.
Who commented
Breakdown by commenter type.
Academic
4
Business
6
Individual
76
Trade association
2
Advocacy
31
Other
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Jul 7, 2025
Jul 21Aug 18Sep 8Oct 20Nov 17Jan 26Jun 29
Support22Oppose92Other6
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
4%
88%
8%
Advocacy
32%
68%
0%
Business
83%
17%
0%
Academic
100%
0%
0%
Trade association
0%
100%
0%
Other
0%
100%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Uncheck an issue to choose another.
| Organization | Abortion access | Mifepristone safety and efficacy | Removal of rems restrictions | Drug safety and efficacy | Impact on intimate partner violence |
|---|---|---|---|---|---|
FemInEM AdvocacySupport FemInEM, a non-profit organization focused on reproductive healthcare in emergency departments, supports the petition to | · | · |
7 organization-typed comments could not be identified.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.